CDRE — Cadre Holdings, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1860543 ·
Last close
$26.39
Market Cap
$1.13B
52W High
$48.44
52W Low
$25.65
ADV30
412,887
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 207,126,000 | 87,135,000 | 23,915,000 | 11,407,000 | 917,298,000 | 53,984,000 | 570,496,000 |
| Mar 2026 | 155,429,000 | 60,166,000 | 9,333,000 | 1,975,000 | 879,736,000 | 41,272,000 | 543,620,000 |
| Dec 2025 | 167,224,000 | 72,623,000 | 21,896,000 | 11,739,000 | 770,031,000 | 122,898,000 | 452,227,000 |
| Sep 2025 | 155,869,000 | 66,625,000 | 20,890,000 | 10,941,000 | 792,055,000 | 150,875,000 | 451,681,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$88,378,000
Investing CF
$-174,038,000
Financing CF
$5,925,000
CapEx
$-10,256,000
Dividends Paid
$-16,289,000
Buybacks
—
EPS Diluted TTM
$0.85
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$39,590,000
Inventory
$129,120,000
Receivables
$128,445,000
ST Investments
—
EBIT TTM
$68,203,000
Pretax Income TTM
$52,254,000
Interest Exp TTM
$15,949,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$685,648,000
EBITDA
$105,895,000
Free Cash Flow
$66,178,248
Enterprise Value
$1,569,099,520
Total Cash
$54,768,000
Total Debt
$400,051,008
Shares Out
42,820,734
Trailing EPS
$0.81
Book Value
$8.10
ROE
10.6%
ROA
6.1%
Div Yield
1.37%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 610,308,000 | 75,047,000 | 44,139,000 | 770,031,000 | 452,227,000 | 317,804,000 | 63,705,000 |
| Dec 2024 | 567,561,000 | 72,768,000 | 36,133,000 | 652,713,000 | 341,198,000 | 311,515,000 | 31,777,000 |
| Dec 2023 | 482,532,000 | 58,711,000 | 38,641,000 | 431,179,000 | 234,017,000 | 197,162,000 | 73,209,000 |
| Dec 2022 | 457,837,000 | 21,071,000 | 5,820,000 | 391,952,000 | 226,062,000 | 165,890,000 | 46,409,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.64
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $25.88 · call volume: 143 · put volume: 119
Expected Move to 2026-10-16:
±$2.82
(10.90%) —
implied range
$23.05 –
$28.70
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AORT | ARTIVION, INC. | $1.10B | $22.63 | — |
| IRMD | IRADIMED CORP | $1.10B | $85.76 | — |
| TNDM | TANDEM DIABETES CARE INC | $1.09B | $15.72 | — |
| ENOV | Enovis CORP | $1.06B | $18.46 | — |
| STVN | Stevanato Group S.p.A. | $1.05B | $21.13 | — |
News headlines (Yahoo Finance, 1h cache)
Cadre Holdings (CDRE) Could Be 44% Undervalued On Its Core Safety Gear Narrative
2026-09-25 20:13 · Yahoo
Cadre Holdings (CDRE) Stock May Be 47% Undervalued On Cash Flow
2026-09-25 01:13 · Yahoo
Cadre Holdings Announces Participation at Upcoming Investor Conferences
2026-08-26 20:15 · Yahoo
Revisiting Former Stock Picks Microsoft, Kingstone, Cadre Holdings
2026-08-20 04:32 · Yahoo
Cadre Holdings (CDRE) Q2 2026 Earnings Call Transcript
2026-08-12 22:13 · Yahoo
CDRE Q2 Deep Dive: M&A, Nuclear Momentum, and Public Safety Demand Drive Guidance Up
2026-08-11 19:01 · Yahoo
Cadre Holdings (CDRE) Is Up 6.2% After Raising 2026 Sales Guidance Despite Softer Earnings
2026-08-11 06:07 · Yahoo
Cadre Q2 Earnings Call Highlights
2026-08-08 01:03 · Yahoo
3 Market-Beating Stocks with Competitive Advantages
2026-08-18 08:21 · Yahoo
2 Industrials Stocks to Target This Week and 1 Facing Challenges
2026-09-24 10:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.